Primary hypertension relative gene and its detecting method and usage
A kind of essential hypertension, gene technology, applied in the direction of genetic engineering, plant genetic improvement, botanical equipment and methods, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0063] Example 1 Rapid detection of C2547 / G polymorphism by direct sequencing
[0064] 1. Obtaining of C2547 / G polymorphic amplification fragment
[0065] The C2547 / G polymorphic amplified fragment (618bp) was obtained by polymerase chain reaction (PCR). For each PCR plate, add 2 samples of DNA template to be tested, 2 cases of control reaction, and 2 cases of blank control reaction without DNA sample. See Table 2 and Table 3 for C2547 / G polymorphic amplification primers and amplification conditions.
[0066] Table 2 C2547 / G polymorphism detection primers
[0067]
[0068] Table 3 C2547 / G polymorphic PCR amplification system and amplification conditions
[0069]
[0070] 2. Identification of C2547 / G polymorphic genotype by direct sequencing of dideoxynucleotide terminal termination method
[0071] After the DNA fragment containing the C2547 / G polymorphism is successfully amplified, first use a commercial PCR product purification plate (for example: Millipore MultiScr...
Embodiment 2
[0086] Example 2 Scientific evidence of linkage between human chromosomal region 8p22 where ADRA1A is located and human essential hypertension and blood pressure level
[0087] Methods: 148 Han Chinese hypertensive families were selected, and the method in Example 1 was used to conduct linkage analysis with SAGE / SIBPAL2 software. The results are shown in Table 5.
[0088] Table 5 The linkage between 8p22 and human blood pressure levels in 148 Han Chinese hypertensive families
[0089]
[0090] Conclusion: As shown in Table 5, there is a linkage between the human chromosome region 8p22 where ADRA1A is located and human essential hypertension and blood pressure levels.
Embodiment 3
[0091] Frequency distribution of embodiment 3C2547 / G polymorphism in case-control samples
[0092] 1. For the description of the clinical characteristics of the case-control samples, see Table 6.
[0093] Table 6 Description of clinical characteristics of case-control samples
[0094]
[0095] Values are mean ± standard deviation. NS, not statistically significant; BMI, body mass index.
[0096] 2. Frequency distribution of C2547 / G polymorphism in case-control samples
[0097] Using the method in Example 1, the above-mentioned cases (n=503) and controls (n=504) were sequenced and analyzed respectively, and the results were statistically analyzed. The results are shown in Table 7.
[0098] Table 7 Frequency distribution of C2547 / G polymorphism in case-control samples
[0099]
[0100] Results: As shown in Table 7, the distribution of the C2547 / G polymorphic G allele in the cases was significantly higher, indicating that the ADRA1A gene is a human essential hypertens...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com
